iSpecimen (ISPC) Net Cash Flow (2020 - 2026)

iSpecimen's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$4.1 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 270.66% year-over-year to -$4.1 million; the TTM figure through Mar 2026 stood at $2.0 million (up 255.89% YoY), while the FY2025 annual figure was $5.0 million, up 1175.19% from the prior year.
• Net Cash Flow was -$4.1 million for Q1 2026 at iSpecimen, down from $4.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $4.1 million in Q4 2025 to a low of -$11.5 million in Q1 2023.
• Historically, Net Cash Flow has averaged -$1.5 million across 5 years, with a median of -$399389.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Net Cash Flow sank 604.11% in 2023, then surged 3138.2% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$5.3 million in 2022, then surged by 92.94% to -$377902.0 in 2023, then surged by 133.49% to $126554.0 in 2024, then soared by 3138.2% to $4.1 million in 2025, then plunged by 199.12% to -$4.1 million in 2026.
• The last three Net Cash Flow figures came in at -$4.1 million (Q1 2026), $4.1 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.